» Articles » PMID: 20153253

The Immunobiology of Aluminium Adjuvants: How Do They Really Work?

Overview
Journal Trends Immunol
Date 2010 Feb 16
PMID 20153253
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Aluminium adjuvants potentiate the immune response, thereby ensuring the potency and efficacy of typically sparingly available antigen. Their concomitant critical importance in mass vaccination programmes may have prompted recent intense interest in understanding how they work and their safety. Progress in these areas is stymied, however, by a lack of accessible knowledge pertaining to the bioinorganic chemistry of aluminium adjuvants, and, consequently, the inappropriate application and interpretation of experimental models of their mode of action. The objective herein is, therefore, to identify the many ways that aluminium chemistry contributes to the wide and versatile armoury of its adjuvants, such that future research might be guided towards a fuller understanding of their role in human vaccinations.

Citing Articles

Additive aluminum as a cause of induced immunoexcitoxicity resulting in neurodevelopmental and neurodegenerative disorders: A biochemical, pathophysiological, and pharmacological analysis.

Blaylock R Surg Neurol Int. 2024; 15:171.

PMID: 38840623 PMC: 11152537. DOI: 10.25259/SNI_296_2024.


Case report: Neglected subacute thyroiditis: a case following COVID-19 vaccination.

Yang S, Guan T, Yang H, Hu Y, Zhao Y Front Med (Lausanne). 2024; 11:1349615.

PMID: 38523906 PMC: 10957742. DOI: 10.3389/fmed.2024.1349615.


Adjuvants in COVID-19 vaccines: innocent bystanders or culpable abettors for stirring up COVID-heart syndrome.

Kanuri S, Sirrkay P Ther Adv Vaccines Immunother. 2024; 12:25151355241228439.

PMID: 38322819 PMC: 10846003. DOI: 10.1177/25151355241228439.


Immunogenicity studies of recombinant RBD SARS-CoV-2 as a COVID-19 vaccine candidate produced in .

Safitri I, Sugijo Y, Puspasari F, Masduki F, Ihsanawati , Giri-Rachman E Vaccine X. 2024; 16:100443.

PMID: 38304876 PMC: 10832452. DOI: 10.1016/j.jvacx.2024.100443.


IgE and anaphylaxis specific to the carbohydrate alpha-gal depend on IL-4.

Hils M, Hoffard N, Iuliano C, Kreft L, Chakrapani N, Swiontek K J Allergy Clin Immunol. 2023; 153(4):1050-1062.e6.

PMID: 38135009 PMC: 10997276. DOI: 10.1016/j.jaci.2023.12.003.